Tamavaq

· Biogenea Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tamavaq, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. [EARLY_Phase 1]

See pricing